Contact Us marketing@medicilon.com
ABOUT
Company Profile
Corporate Culture
Management Team
Company History
Message from the CEO
Honors and Awards
SERVICES
SERVICES
01 Drug Discovery
Chemistry Research Biology Research Early Pharmacokinetics
02 Pharmaceutical Research
Intermediates Active Pharmaceutical Ingredients Pharmaceutical preparation Analytical Method Development and Quality Control CMC Filings Analytical Testing Center
03 Preclinical Research
Pharmacology & Pharmacodynamics Drug Safety Evaluation DMPK Bioanalysis IND Filings
PLATFORM
PLATFORM
01 One-stop Integrated Services
Liposome Drug Development Drug Discovery Pharmaceutical Research Preclinical Research Botanical Drug Preclinical R&D
02 Innovative Drug R&D Services
Peptide Drug Conjugate (PDC) Antibody Nucleic Acid Drug Cellular Immunotherapies mRNA Vaccine PROTAC ADC
03 Key Technical Services for Drug R&D
Cytokine and Biomarker Detection Metabolite Identification (MetID) Drug Forming Research Flow Cytometry Technology SEND Format Conversion Flow Sorting NanoString nCounter Detection Routes of Drug Administration
04 Drug Efficacy Evaluation for Common Diseases
Rodent Cerebrovascular Disease Inflammatory and Immune Diseases IO Pharmacodynamic Model
05 High-end Preparations Technology Platform
Skin Topical Preparation Ophthalmic drug Inhalation drug
06 Targeted Drugs R&D Services
STAT3-targeted Drugs R&D Service KRAS-targeted Drugs R&D Service GLP-1 New Drug R&D Service
07 Safety Assessment Lab of Process Chemistry

08 Public Services
CAREERS
Talent Development
Campus Recruitment
Recruitment
NEWS
Medicilon Events
Featured Stories
Market Events
Videos
A.C.E.
INVESTORS
Stock Information
Investment Contact
CLIENT CENTER
Intellectual Property Protection
Clients Testimonials
Downloads
Partnerships
Medicilon Support
Newsletters
CN
×
中
Message
Contact Us
Close Button
Back To Top
Online Message×
Click switch
Close Button
Medicilon Events
News and Events
Medicilon Events Featured Stories Market Events Videos A.C.E.
HomenewsMedicilon Events

Medicilon Events

Hot information：
Medicilon Appoints Dr. Liu Jian as President of Drug Discovery Division| Medicilon and Wuhan biolake successfully organized a biopharmaceutical salon| Medicilon FTE services & FFS services - flexible and efficient cooperation model
Dec 01,2020
Medicilon's Immuno-oncology Models Evaluation Platform
In recent years, tumor immunotherapy has become the core of cancer treatment research. With innovation as the driving force, Medicilon has vigorously developed a tumor
More
Medicilon's Immuno-oncology Models Evaluation Platform
Nov 24,2020
Medicilon Wish You a Safe, Healthy and Warm Thanksgiving
#medicilon #thanksgiving #drugdiscovery
More
Medicilon Wish You a Safe, Healthy and Warm Thanksgiving
Nov 16,2020
Medicilon will participate ACT 2020 Annual Meeting
#Medicilon will exhibit the ACT 2020 Annual Meeting Nov 12-19.  Please visit our virtual booth for our #toxicology services.  We look forward to see you.
More
Medicilon will participate ACT 2020 Annual Meeting
Nov 11,2020
Medicilon will participate SAPA-CT Annual Conference
Medicilon will exhibit the SAPA-CT Annual Conference on Nov 14, 2020.  Our CEO, Dr. Chunlin Chen, is invited to give a presentation on the topic
More
Medicilon will participate SAPA-CT Annual Conference
Oct 31,2020
ABM Therapeutics presented Medicilon with a commemorative trophy of "our first candidate compound"
On October 31, 2020, ABM Therapeutics awarded the "Our First Candidate Compound" commemorative trophy to Dr. Li Zhigang, Vice President of Research and Development of Medicilon Chemistry Department, to thank Medicilon for its FTE form of cooperation, the pharmaceutical and chemical team helped it discover and advance the first drug candidate ABM-1310 to enter the clinical phase I in the United States.
More
ABM Therapeutics presented Medicilon with a commemorative trophy of "our first candidate compound"
Oct 19,2020
Medicilon-Phenomenex Chiral Segmentation Joint Laboratory Unveiling Ceremony
Shanghai, China, October 15, 2020-Shanghai Medicilon and Phenomenex reached a strategic agreement to jointly build a chemistry laboratory for chiral interchange and further enhance the
More
Medicilon-Phenomenex Chiral Segmentation Joint Laboratory Unveiling Ceremony
Oct 17,2020
Medicilon won two awards at The 15th Award of competitive and trustworthy listed companies
Oct 16th, Hainan, China—The 15th Award of competitive and trustworthy listed companies in China was held in Sanya, Hainan. The theme of the forum was
More
Medicilon won two awards at The 15th Award of competitive and trustworthy listed companies
Sep 28,2020
Medicilon will participate 2020 SAPA Annual Conference
Due to the COVID-19 pandemic, the 2020 SAPA Healthcare Investment Forum & Roadshow will be divided in 2 parts.  Part I will be hosted as
More
Medicilon will participate 2020 SAPA Annual Conference
Sep 21,2020
Medicilon is honored as TOP 20 R&D CRO Enterprises in China
Chongqing, September 10, 2020 – 2020 Conference on High Quality Development of Healthcare Industry & the Fifth China Pharmaceutical R&D and Innovation Summit was held
More
Medicilon is honored as TOP 20 R&D CRO Enterprises in China
Sep 05,2020
Online Seminar for Identification and validation of novel therapeutic targets in both breast and kidney cancers
Please reserve for your seat at the below eventbrite link for free. https://www.eventbrite.com/e/novel-therapeutic-targets-in-both-breast-and-kidney-cancers-tickets-119195604261 Hypoxia is associated with resistance towards radiation and chemotherapy. As tumors grow,
More
Online Seminar for Identification and validation of novel therapeutic targets in both breast and kidney cancers
Aug 20,2020
A seminar on preclinical R&D strategic cooperation was held between Medicilon and Yichang Humanwell
Yichang, Hubei, Aug 13, 2020 – A seminar on preclinical R&D strategic cooperation was held between Medicilon. INC (Stock Code: 688202. SH) and Yichang Humanwell
More
A seminar on preclinical R&D strategic cooperation was held between Medicilon and Yichang Humanwell
Aug 13,2020
Medicilon will participate in ACS Fall 2020 Virtual Meeting & Expo
Medicilon will exhibit the ACS Fall 2020 Virtual Meeting & Expo from Aug 17-20.  Please visit https://calendly.com/fywang to schedule a 1-on-1 meeting with our VP
More
Medicilon will participate in ACS Fall 2020 Virtual Meeting & Expo
Stock Code
688202

Global

Address: 20 Maguire Road, Suite 103, Lexington, MA 02421(America)

Tel: +1(781)535-1428(U.S.)

Address: Allia Future Business Centre Kings Hedges Road Cambridge CB4 2HY, UK

Tel: 0044 7790 816 954 (Europe)

Email: marketing@medicilon.com

  

Address: 5th Floor, 62, Banpodae-ro 4-gil, Seocho-gu, Seoul, 06719 South Korea

Tel: +82 70-8269-5849

China

Address: No.585 Chuanda Road, Pudong New Area, Shanghai (Headquarters)

Postcode: 201299

Tel: +86 (21) 5859-1500 (main line)

Fax: +86 (21) 5859-6369

Facebook icon
Twitter icon
Linkedin icon
Youtube icon
© 2023 Shanghai Medicilon Inc. All rights reserved All Rights Reserved Privacy Policy
Website Map
-->